- Home
- VBIX vs IGC Comparison
VBIX vs IGC Comparison
Compare VBIX & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VBIX
- IGC
- Stock Information
- Founded
- VBIX N/A
- IGC 2005
- Country
- VBIX Israel
- IGC United States
- Employees
- VBIX N/A
- IGC N/A
- Industry
- VBIX Computer Software: Prepackaged Software
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- VBIX Technology
- IGC Health Care
- Exchange
- VBIX Nasdaq
- IGC Nasdaq
- Market Cap
- VBIX 34.9M
- IGC 33.8M
- IPO Year
- VBIX N/A
- IGC N/A
- Fundamental
- Price
- VBIX $1.91
- IGC $0.36
- Analyst Decision
- VBIX
- IGC Strong Buy
- Analyst Count
- VBIX 0
- IGC 2
- Target Price
- VBIX N/A
- IGC $4.00
- AVG Volume (30 Days)
- VBIX 78.5K
- IGC 933.0K
- Earning Date
- VBIX 08-14-2025
- IGC 11-14-2025
- Dividend Yield
- VBIX N/A
- IGC N/A
- EPS Growth
- VBIX N/A
- IGC N/A
- EPS
- VBIX N/A
- IGC N/A
- Revenue
- VBIX $11,056,000.00
- IGC $1,106,000.00
- Revenue This Year
- VBIX N/A
- IGC $3.54
- Revenue Next Year
- VBIX N/A
- IGC $15.12
- P/E Ratio
- VBIX N/A
- IGC N/A
- Revenue Growth
- VBIX N/A
- IGC N/A
- 52 Week Low
- VBIX $1.80
- IGC $0.25
- 52 Week High
- VBIX $9.80
- IGC $0.50
- Technical
- Relative Strength Index (RSI)
- VBIX 31.33
- IGC 37.23
- Support Level
- VBIX $1.89
- IGC $0.35
- Resistance Level
- VBIX $2.10
- IGC $0.40
- Average True Range (ATR)
- VBIX 0.20
- IGC 0.03
- MACD
- VBIX -0.13
- IGC -0.00
- Stochastic Oscillator
- VBIX 13.51
- IGC 22.64
About VBIX Viewbix Inc. Common Stock
ViewBix Inc operates in the field of digital advertising. Along with its subsidiaries, the company performs two main activities that are reported as separate operating segments: the search segment and the digital content segment. Maximum revenue is generated from the digital content segment, which is engaged in the creation and editing of content, in different languages, for different target audiences, to generate revenues from advertising platforms, including Google, Facebook, Yahoo, and Apple, by utilizing such content to obtain internet user traffic for its customers. The search segment develops various technological software solutions, which perform automation, optimization, and monetization of internet campaigns, to obtain and route internet user traffic to its customers.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.